Chargement en cours...
Caveat mTOR: aberrant signaling disrupts corticogenesis
The mammalian target of rapamycin (mTOR) signaling pathway is activated in several disorders associated with benign tumors and malformations of the cerebral cortex. In this issue of the JCI, Orlova et al. have now definitively added another disorder to this group by demonstrating that activation of...
Enregistré dans:
| Auteur principal: | |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
American Society for Clinical Investigation
2010
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2860937/ https://ncbi.nlm.nih.gov/pubmed/20424320 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1172/JCI43030 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|